Physician profile
Marc T Downing
NPI 1083694699
$431.88
in general payments reported to CMS, 2019-2025
11 companies · $93.92 in 2025
The $93.92 reported for 2025 was less than what a typical Pediatric Surgery provider received nationally (typical 2025 total: $136).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.58 · 2020: $25.77 · 2021: $125 · 2022: $31.24 · 2023: $33.05 · 2024: $94.32 · 2025: $93.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $221.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $125.00 | 2021 | |
| Ethicon US, LLC | $69.55 | 2022-2025 | Endopath Xcel, Megadyne |
| Bolder Surgical LLC | $40.77 | 2019-2020 | |
| Ipsen Biopharmaceuticals, INC | $34.03 | 2024 | Bylvay |
| Integra Lifesciences Corporation | $33.05 | 2023 | Integra, Omnigraft, Surgimend |
| Regeneron Healthcare Solutions, INC. | $31.96 | 2024 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $27.81 | 2024-2025 | Eohilia |
| Janssen Biotech, INC. | $24.16 | 2025 | Tremfya |
| Bard Peripheral Vascular, INC. | $16.87 | 2025 | |
| Novo Nordisk INC | $15.10 | 2024 | Wegovy |
| Conmed Corporation | $13.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Downing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.